Amiculum published a blog by Craig Tallentire, PhD discussing What can obesity medicines teach us about launching future mass-market therapies.

Amiculum is an independent healthcare consulting and communications agency with >300 talented team members in key locations worldwide. For over two decades, we’ve partnered with visionary pharmaceutical companies and external medical experts, building connections across the healthcare community and communicating groundbreaking science. We amplify the scientific advances that transform healthcare. Taking our clients’ science, we create evidence-based narratives that ignite understanding and inspire action across the healthcare community. Because when science speaks clearly, it transforms lives. Let us show you how we can make your science speak volumes. Visit our website today!